Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

Apple, Enthusiast Gaming, Lufthansa - Profiteers, victims and opportunities

Since the outbreak of the corona virus and its subsequent spread, more and more countries and regions have had to pass sanctions to contain the risk of infection. The first country to be affected was China, the country of origin of Covid-19, the current corona virus. With dras...

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...

Protagonist Therapeutics Shares Trade Up 70% on Phase 2 Transfusion Trial Results

Newark, Calif.-based Protagonist Therapeutics' shares traded 70% higher today after the firm reported preliminary Phase 2 results for Hepcidin Mimetic PTG-300 in the treatment of transfusion dependent beta-thalassemia. Clinical-stage biopharmaceutical company Protago...

Hidden dangers of rising commodity prices

"If they're just processors, forget them... Shoot them, in fact." Jeremy Grantham is a legend on Wall Street. He called the top of the Japanese economy in 1989, the top of the tech bubble in 2000, and the bottom of the stock market in 2009. When he talks, investors liste...

Protagonist's Shares Nearly Double After Reporting Q1 Earnings and Positive Phase 2 Trial Results

Shares of Protagonist Therapeutics traded higher and reached a new 52-week high price after the company released Q1/20 financial results and positive data from its Phase 2 study of PTG-300 in patients with polycythemia vera, a type of blood cancer. After U.S...

Smart City Security Takes Shape in Mexico City with Lighting and Analytics Collaboration

The two firms are bringing together lighting, cameras and analytic technology. Energetika, an international firm based in Mexico City that provides intelligent lighting solutions, is collaborating with VSBLTY Groupe Technologies Corp. (VSBY:CSE; VSBGF:OTC; 5VS:FRA) ,...

The Wuhan Wipeout – Could It Happen?

News is traveling fast about the Corona Virus that originated in Wuhan, China. Two new confirmed cases in the US, one in Europe and hundreds in China. As we learn more about this potential pandemic outbreak, we are learning that China did very little to contain this problem fr...

Barrick Gold, Royal Dutch Shell, Newmont - which shares should you have now?

Stock markets around the world are in recovery mode. Fear and panic over the spread of the corona virus is fading and greed is returning. COVID-19 has kept the world in suspense. After hesitant action by governments in Europe and North America, although curfews were imposed in...

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...

The Golden Bullet for Drug Delivery

It’s the Holy Grail in the cannabis industry. Everyone is trying to innovate the best delivery system to optimize the “bioavailability” (uptake) of medical cannabis in order to offer the perfect pairing -- precise dosing with a fast on...
1 2 3